Evaluating the Economic Implications of Using Machine Learning in Clinical Psychiatry

With the growing interest in using AI and machine learning (ML) in medicine, there is an increasing number of literature covering the application and ethics of using AI and ML in areas of medicine such as clinical psychiatry. The problem is that there is little literature covering the economic aspects associated with using ML in clinical psychiatry. This study addresses this gap by specifically studying the economic implications of using ML in clinical psychiatry. In this paper, we evaluate the economic implications of using ML in clinical psychiatry through using three problem-oriented case studies, literature on economics, socioeconomic and medical AI, and two types of health economic evaluations. In addition, we provide details on fairness, legal, ethics and other considerations for ML in clinical psychiatry.

Towards a New Participatory Approach for Designing Artificial Intelligence and Data-Driven Technologies

With there being many technical and ethical issues with artificial intelligence (AI) that involve marginalized communities, there is a growing interest for design methods used with marginalized people that may be transferable to the design of AI technologies. Participatory design (PD) is a design method that is often used with marginalized communities for the design of social development, policy, IT and other matters and solutions. However, there are issues with the current PD, raising concerns when it is applied to the design of technologies, including AI technologies. This paper argues for the use of PD for the design of AI technologies, and introduces and proposes a new PD, which we call agile participatory design, that not only can could be used for the design of AI and data-driven technologies, but also overcomes issues surrounding current PD and its use in the design of such technologies.